title: Enhanced specificity of the viral suppressor of RNA silencing protein p19 toward sequestering of human microRNA-122.
abstract: Tombusviruses express a 19 kDa protein (p19) that, as a dimeric protein, suppresses the RNAs silencing pathway during infection by binding short-interfering RNA (siRNA) and preventing their association with the RNA-induced silencing complex (RISC). The p19 protein can bind to both endogenous and synthetic siRNAs with a high degree of size selectivity but with little sequence dependence. It also binds to other endogenous small RNAs such as microRNAs (miRNAs) but with lower affinity than to canonical siRNAs. It has become apparent, however, that miRNAs play a large role in gene regulation; their influence extends to expression and processing that affects virtually all eukaryotic processes. In order to develop new tools to study endogenous small RNAs, proteins that suppress specific miRNAs are required. Herein we describe mutational analysis of the p19 binding surface with the aim of creating p19 mutants with increased affinity for miR-122. By site-directed mutagenesis of a single residue, we describe p19 mutants with a nearly 50-fold increased affinity for miR-122 without altering the affinity for siRNA. Upon further mutational analysis of this site, we postulate that the higher affinity relies on hydrogen-bonding interactions but can be sterically hindered by residues with bulky side chains. Finally, we demonstrate the effectiveness of a mutant p19, p19-T111S, at sequestering miR-122 in human hepatoma cell lines, as compared to wild-type p19. Overall, our results suggest that p19 can be engineered to enhance its affinity toward specific small RNA molecules, particularly noncanonical miRNAs that are distinguishable based on locations of base-pair mismatches. The p19-T111S mutant also represents a new tool for the study of the function of miR-122 in post-transcriptional silencing in the human liver.
authors.affiliation: Steacie Institute for Molecular Sciences, National Research Council of Canada, Ottawa, Canada K1A 0R6.
authors.forename: Jenny
authors.initials: J
authors.lastname: Cheng
authors.forename: Dana C
authors.initials: DC
authors.lastname: Danielson
authors.forename: Neda
authors.initials: N
authors.lastname: Nasheri
authors.forename: Ragunath
authors.initials: R
authors.lastname: Singaravelu
authors.forename: John Paul
authors.initials: JP
authors.lastname: Pezacki
mesh_terms: D001665:Binding Sites; D045744:Cell Line, Tumor; D002942:Circular Dichroism; D016679:Genome, Viral; D006801:Humans; D006860:Hydrogen Bonding; D035683:MicroRNAs / Q000737:chemistry* / Q000235:genetics; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D034622:RNA Interference; D014026:Nicotiana / Q000378:metabolism; D017864:Tombusvirus / Q000235:genetics / Q000378:metabolism; D014162:Transfection; D014764:Viral Proteins / Q000737:chemistry* / Q000235:genetics
chemical_list: C531907:MIRN122 microRNA, human; D035683:MicroRNAs; D014764:Viral Proteins